Extreme Biodiesel, Inc.
XTRM · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,336 | $2,135 | $2,175 | $0 |
| % Growth | -37.4% | -1.9% | – | – |
| Cost of Goods Sold | $1,268 | $1,584 | $2,819 | $35 |
| Gross Profit | $68 | $551 | -$644 | -$35 |
| % Margin | 5.1% | 25.8% | -29.6% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $92 | $31 | $51 | $54 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $92 | $31 | $51 | $54 |
| Operating Income | -$25 | $520 | -$695 | -$89 |
| % Margin | -1.9% | 24.4% | -32% | – |
| Other Income/Exp. Net | -$93 | -$64 | -$147 | -$59 |
| Pre-Tax Income | -$118 | $456 | -$842 | -$148 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$118 | $456 | -$842 | -$148 |
| % Margin | -8.8% | 21.4% | -38.7% | – |
| EPS | -0 | 0 | -0 | -0 |
| % Growth | -123.9% | 150% | -300% | – |
| EPS Diluted | -0 | 0 | -0 | -0 |
| Weighted Avg Shares Out | 2,464,000 | 1,888,000 | 1,888,000 | 1,749,096 |
| Weighted Avg Shares Out Dil | 2,464,000 | 1,888,000 | 1,888,000 | 1,749,096 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $102 | $55 | $147 | $59 |
| Depreciation & Amortization | $35 | $35 | $35 | $35 |
| EBITDA | $10 | $555 | -$660 | -$54 |
| % Margin | 0.8% | 26% | -30.3% | – |